Healthcare - Sector
I-Mab's activity chart (see below) currently has 55 price targets and 63 ratings on display.
Analysts' price targets on this stock were met 49.82% of the time, taking 152.13 days on average.
Most recent stock forecast was given by JUSTIN ZELIN from BTIG on 24-Oct-2025. First documented stock forecast 11-Feb-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Sep-2025
$9
$9
1 years 29 days ago
(24-Oct-2025)
0/3 (0%)
$4.78 (113.27%)
Buy Since 02-Nov-2021
$6
$6
1 years 2 months 14 days ago
(08-Sep-2025)
4/10 (40%)
$1.73 (40.52%)
44
Buy Since 09-Jul-2025
$7
$7
1 years 3 months 1 days ago
(21-Aug-2025)
0/2 (0%)
$2.29 (48.62%)
Buy Since 07-Dec-2020
$7
1 years 4 months 26 days ago
(27-Jun-2025)
2/7 (28.57%)
$4.63 (195.36%)
59
Buy Since 25-Feb-2021
$8
$10
2 years 2 months 6 days ago
(16-Sep-2024)
3/5 (60%)
$6.94 (654.72%)
373
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst most recently updated their price target on IMAB (I-Mab)?
Which analyst has the lowest performance score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?